155 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Recruiting Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Procedure: colonoscopy with endomicroscopy
22 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
23 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA) withdrawal and reinstitution
24 Recruiting Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: norUDCA;   Drug: Placebo
25 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
26 Recruiting Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
Condition: Indeterminate Bile Duct Stricture
Interventions: Procedure: Multiple brushings;   Procedure: Multimodality tissue sampling
27 Unknown  Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
Condition: Cholestasis
Intervention: Drug: tauroursodeoxycholic acid
28 Recruiting Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
Conditions: Pancreatic Tumor;   Bile Duct Tumor
Intervention: Dietary Supplement: Oral IMPACT
29 Recruiting Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
Condition: Benign Bile Duct Strictures
Interventions: Device: Fully covered Metallic Stent;   Device: Plastic Stent
30 Not yet recruiting Treatment for Bile Duct Cancer in the Liver
Condition: Hepatocellular Carcinoma
Intervention: Drug: SIRT Yttrium-90
31 Unknown  Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Conditions: Cancer of Bile Duct;   Pancreatic Cancer
Intervention: Device: PTFE Covered ComVi [full covered] Biliary Stent
32 Unknown  Minimization of IntraLipid Versus Omegaven
Conditions: Cholestasis;   Parenteral Nutrition Associated Liver Disease (PNALD)
Interventions: Dietary Supplement: Omegaven;   Dietary Supplement: Lipid minimization
33 Unknown  Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention:
34 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
35 Recruiting EUS-guided Biliary Drainage Versus Percutanenous Transhepatic Biliary Darinage for Malignant Biliary Obstruction After Failed ERCP
Condition: Cholestasis, Extrahepatic
Interventions: Device: EUS-BD;   Device: PTBD
36 Not yet recruiting An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome
Condition: Alagille Syndrome
Intervention: Drug: LUM001
37 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
38 Recruiting Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction
Condition: Malignant Tumor of Extrahepatic Bile Duct
Interventions: Device: WInged perimeter biliary stent insertion (Viaduct);   Device: traditional polyethylene stent insertion (Cotton Huibregtse)
39 Unknown  Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Conditions: Cholestasis;   Prematurity;   Gastroschisis;   Intestinal Atresia;   Necrotizing Enterocolitis
Intervention: Drug: Parenteral Nutrition
40 Recruiting Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Condition: Total Parenteral Nutrition-induced Cholestasis
Intervention: Drug: Omegaven®

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years